Effects of dietary glutamine on adhesion molecule expression and oxidative stress in mice with streptozotocin-induced type 1 diabetes

Clinical Nutrition

Volumn 30, Issue 1, 2011, Pages 124-129

  Tsai, Pei Hsuan ^a   Liu, Jun Jen ^a   Chiu, Wan Chun ^a   Pai, Man Hui ^a   Yeh, Sung Ling ^a  

^a TAIPEI MEDICAL UNIVERSITY   (Taiwan)

Author keywords

Adhesion molecule; Glutamine; Glutathione; Nitrotyrosine; Type 1 diabetes

Indexed keywords

3 NITROTYROSINE; CD18 ANTIGEN; CELL ADHESION MOLECULE; FRUCTOSAMINE; GLUCOSE; GLUTAMINE; GLUTATHIONE; LYMPHOCYTE FUNCTION ASSOCIATED ANTIGEN 1; MYELOPEROXIDASE; STREPTOZOCIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIGEN EXPRESSION; ARTICLE; CONTROLLED STUDY; DIET SUPPLEMENTATION; ENZYME ACTIVITY; GLUCOSE BLOOD LEVEL; INSULIN DEPENDENT DIABETES MELLITUS; LEUKOCYTE; MALE; MOUSE; NONHUMAN; OXIDATIVE STRESS; PROTEIN EXPRESSION; TISSUE DISTRIBUTION;

ANALYSIS OF VARIANCE; ANIMALS; BLOOD GLUCOSE; CELL ADHESION MOLECULES; DIABETES MELLITUS, EXPERIMENTAL; DIABETES MELLITUS, TYPE 1; DIET; DIETARY SUPPLEMENTS; FRUCTOSAMINE; GLUTAMINE; GLUTATHIONE; INSULIN; LEUKOCYTES; MALE; MICE; MICE, INBRED ICR; OXIDATIVE STRESS; STREPTOZOCIN; TYROSINE;

EID: 79451470232     PISSN: 02615614     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.clnu.2010.07.005     Document Type: Article

References (39)

1. Department of Health, Taiwan Top 10 leading causes of death in Taiwan 2009, http://www.doh.gov.tw.
2. Roth E., Oehler R., Manhart N., Exner R., Wessner B., Strasser E., et al. Regulative potential of glutamine-relation to glutathione metabolism. Nutrition 2002, 18:217-221.
3. Parillo M., Riccardi G. Diet composition and the risk of type 2 diabetes: epidemiological and clinical evidence. Br J Nutr 2004, 92:7-19.
4. Daneman D. Type 1 diabetes. Lancet 2006, 367:847-858.
5. Goh S.Y., Cooper M.E. Clinical review: the role of advanced glycation end products in progression and complications of diabetes. J Clin Endocrinol Metab 2008, 93:1143-1152.
6. Nystrom T., Nygren A., Sjoholm A. Increased levels of tumour necrosis factor-alpha (TNF-alpha) in patients with type II diabetes mellitus after myocardial infarction are related to endothelial dysfunction. Clin Sci (Lond) 2006, 110:673-681.
7. Carlos T.M., Harlan J.M. Leukocyte-endothelial adhesion molecules. Blood 1994, 84:2068-2101.
8. Jang Y., Lincoff A.M., Plow E.F., Topol E.J. Cell adhesion molecules in coronary artery disease. J Am Coll Cardiol 1994, 24:1591-1601.
9. Henderson R.B., Lim L.H., Tessier P.A., Gavins F.N., Mathies M., Perretti M., et al. The use of lymphocyte function-associated antigen (LFA)-1-deficient mice to determine the role of LFA-1, Mac-1, and alpha4 integrin in the inflammatory response of neutrophils. J Exp Med 2001, 194:219-226.
10. Ulbrich H., Eriksson E.E., Lindbom L. Leukocyte and endothelial cell adhesion molecules as targets for therapeutic interventions in inflammatory disease. Trends Pharmacol Sci 2003, 24:640-647.
11. Nolte D., Kuebler W.M., Muller W.A., Wolff K.D., Messmer K. Attenuation of leukocyte sequestration by selective blockade of PECAM-1 or VCAM-1 in murine endotoxemia. Eur Surg Res 2004, 36:331-337.
12. Glowinska B., Urban M., Peczynska J., Florys B. Soluble adhesion molecules (sICAM-1, sVCAM-1) and selectins (sE selectin, sP selectin, sL selectin) levels in children and adolescents with obesity, hypertension, and diabetes. Metabolism 2005, 54:1020-1026.
13. Wilmore D.W. The effect of glutamine supplementation in patients following elective surgery and accidental injury. J Nutr 2001, 131:2543S-2549S.
14. Wischmeyer P.E., Kahana M., Wolfson R., Ren H., Musch M.M., Chang E.B. Glutamine reduces cytokine release, organ damage, and mortality in a rat model of endotoxemia. Shock 2001, 16:398-402.
15. Gianotti L., Alexander J.W., Gennari R., Pyles T., Babcock G.F. Oral glutamine decreases bacterial translocation and improves survival in experimental gut-origin sepsis. J Parenter Enteral Nutr 1995, 19:69-74.
16. Yeh S.L., Lai Y.N., Shang H.F., Lin M.T., Chen W.J. Effects of glutamine supplementation on innate immune response in rats with gut-derived sepsis. Br J Nutr 2004, 91:423-429.
17. Menge B.A., Schrader H., Ritter P.R., Ellrichmann M., Uhl W., Schmidt W.E., et al. Selective amino acid deficiency in patients with impaired glucose tolerance and type 2 diabetes. Regul Pept 2010, 160:75-80.
18. Opara E.C., Petro A., Tevrizian A., Feinglos M.N., Surwit R.S. L-Glutamine supplementation of a high fat diet reduces body weight and attenuates hyperglycemia and hyperinsulinemia in C57BL/6J mice. J Nutr 1996, 126:273-279.
19. Greenfield J.R., Farooqi I.S., Keogh J.M., Henning E., Habib A.M., Blackwood A., et al. Oral glutamine increases circulating glucagon-like peptide 1, glucagon, and insulin concentrations in lean, obese, and type 2 diabetic subjects. Am J Clin Nutr 2009, 89:106-113.
20. Hong B.N., Kang T.H. Auditory neuropathy in streptozotocin-induced diabetic mouse. Neurosci Lett 2008, 431:268-272.
21. Fujita A., Sasaki H., Ogawa K., Okamoto K., Matsuno S., Matsumoto E., et al. Increased gene expression of antioxidant enzymes in KKAy diabetic mice but not in STZ diabetic mice. Diabetes Res Clin Pract 2005, 69:113-119.
22. Huang Y., Chen J., Li G., Cheng T.Y., Jiang M.H., Zhang S.Y., et al. Reversal of hyperglycemia by protein transduction of NeuroD in vivo. Acta Pharmacol Sin 2007, 28:1181-1188.
23. Kew S., Wells S.M., Yaqoob P., Wallace F.A., Miles E.A., Calder P.C. Dietary glutamine enhances murine T-lymphocyte responsiveness. J Nutr 1999, 129:1524-1531.
24. Wells S.M., Kew S., Yaqoob P., Wallace F.A., Calder P.C. Dietary glutamine enhances cytokine production by murine macrophages. Nutrition 1999, 15:881-884.
25. Chung H.F., Lees H., Gutman S.I. Effect of nitroblue tetrazolium concentration on the fructosamine assay for quantifying glycated protein. Clin Chem 1988, 34:2106-2111.
26. Hillegass L.M., Griswold D.E., Brickson B., Albrightson-Winslow C. Assessment of myeloperoxidase activity in whole rat kidney. J Pharmacol Methods 1990, 24:285-295.
27. Tietze F. Enzymatic method for quantitative determination of nanogram amounts of total and oxidized glutathione: applications to mammalian blood and other tissues. Anal Biochem 1969, 27:502-522.
28. Zhang L., Zalewski A., Liu Y., Mazurek T., Cowan S., Martin J.L., et al. Diabetes-induced oxidative stress and low-grade inflammation in porcine coronary arteries. Circulation 2003, 108:472-478.
29. Pai M.H., Chien Y.W., Tsai Y.H., Hu Y.M., Yeh S.L. Glutamine reduces the expression of leukocyte integrins leukocyte function-associated antigen-1 and macrophage antigen-1 in mice exposed to arsenic. Nutr Res 2008, 28:544-549.
30. Arndt H., Kullmann F., Reuss F., Scholmerich J., Palitzsch K.D. Glutamine attenuates leukocyte-endothelial cell adhesion in indomethacin-induced intestinal inflammation in the rat. J Parenter Enteral Nutr 1999, 23:12-18.
31. Kettle A.J., Winterbourn C.C. Myeloperoxidase: a key regulator of neutrophil oxidant producation. Redox Rep 1997, 3:3-15.
32. Gaut J.P., Yeh G.C., Tran H.D., Byun J., Henderson J.P., Richter G.M., et al. Neutrophils employ the myeloperoxidase system to generate antimicrobial brominating and chlorinating oxidants during sepsis. Proc Natl Acad Sci U S A 2001, 98:11961-11966.
33. Kuhns D.B., Alvord W.G., Gallin J.I. Increased circulating cytokines, cytokine antagonists, and E-selectin after intravenous administration of endotoxin in humans. J Infect Dis 1995, 171:145-152.
34. Li N., Liboni K., Fang M.Z., Samuelson D., Lewis P., Patel R., et al. Glutamine decreases lipopolysaccharide-induced intestinal inflammation in infant rats. Am J Physiol Gastrointest Liver Physiol 2004, 286:G914-G921.
35. Piconi L., Quagliaro L., Ceriello A. Oxidative stress in diabetes. Clin Chem Lab Med 2003, 41:1144-1149.
36. De Mattia G., Bravi M.C., Laurenti O., Cassone-Faldetta M., Armiento A., Ferri C., et al. Influence of reduced glutathione infusion on glucose metabolism in patients with non-insulin-dependent diabetes mellitus. Metabolism 1998, 47:993-997.
37. Yu J.C., Jiang Z.M., Li D.M., Yang N.F., Bai M.X. Alanyl-glutamine preserves hepatic glutathione stores after 5-FU treatment. Clin Nutr 1996, 15:261-265.
38. Babu R., Eaton S., Drake D.P., Spitz L., Pierro A. Glutamine and glutathione counteract the inhibitory effects of mediators of sepsis in neonatal hepatocytes. J Pediatr Surg 2001, 36:282-286.
39. Sen C.K. Nutritional biochemistry of cellular glutathione. J Nutr Biochem 1997, 8:660-672.